The convergence of artificial intelligence and biotechnology presents a dual-edged challenge for policymakers worldwide. While these technological advances promise revolutionary medical breakthroughs and improved patient outcomes, security experts warn of emerging risks from malicious actors exploiting AI for bioterrorism purposes. Washington faces critical decisions regarding regulatory frameworks and international protocols to harness innovation benefits while preventing catastrophic biosecurity threats.

Summary auto-generated by AI from the original publisher's content. Editorial standards.